Long COVID in Hospitalized COVID-19 Patients: A Retrospective Cohort Study

Background: We aimed to evaluate the Long COVID frequency, and related factors in patients followed up after hospitalization. Methods: This retrospective cohort study included 133 inpatients with COVID-19 PCR test positivity from Nigde Province, Turkey between 01.01.2021 and 28.02.2021. The characte...

Full description

Saved in:
Bibliographic Details
Main Authors: Neşe Yakşi (Author), Ayşe Gülsen Teker (Author), Ayfer İmre (Author)
Format: Book
Published: Tehran University of Medical Sciences, 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_de3a056d53dd4eb7b96e87b8b0c975d4
042 |a dc 
100 1 0 |a Neşe Yakşi  |e author 
700 1 0 |a Ayşe Gülsen Teker  |e author 
700 1 0 |a Ayfer İmre  |e author 
245 0 0 |a Long COVID in Hospitalized COVID-19 Patients: A Retrospective Cohort Study 
260 |b Tehran University of Medical Sciences,   |c 2022-01-01T00:00:00Z. 
500 |a 10.18502/ijph.v51i1.8297 
500 |a 2251-6085 
500 |a 2251-6093 
520 |a Background: We aimed to evaluate the Long COVID frequency, and related factors in patients followed up after hospitalization. Methods: This retrospective cohort study included 133 inpatients with COVID-19 PCR test positivity from Nigde Province, Turkey between 01.01.2021 and 28.02.2021. The characteristics of the patients were recorded by examining the files, and the symptom questioning was made by telephone interviewing with the patients approximately four months after the date of diagnosis. The presence of at least one symptom lasting more than four weeks was described as Long COVID. Results: The frequency of Long COVID was 64.7%. The most common Long COVID symptoms were fatigue (45.9%), respiratory distress (25.6%), and muscle / joint pain (24.8%), respectively. In comparison analysis to identify factors associated with Long COVID; Long COVID was found to be more frequent among women (P=0.04); patients with severe COVID-19 (P<0.01), patients with prolonged hospital stay (P=0.03), patients with the comorbid disease (P=0.03), and Diabetes Mellitus patients (P=0.02). Additionally, the frequency of Long COVID increased as the depression score stated by the person increased after COVID-19 disease (P=0.02). Conclusion:  The treatment of COVID-19 patients should not end when they are discharged from the hospital. On the contrary, these patients, especially high-risk patients, should be followed up in post-COVID clinics and rehabilitated physically and psychosocially with a multidisciplinary approach following the recovery period of the acute illness. 
546 |a EN 
690 |a Long COVID 
690 |a COVID-19 
690 |a Symptom 
690 |a Hospital 
690 |a Turkey 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Iranian Journal of Public Health, Vol 51, Iss 1 (2022) 
787 0 |n https://ijph.tums.ac.ir/index.php/ijph/article/view/26637 
787 0 |n https://doaj.org/toc/2251-6085 
787 0 |n https://doaj.org/toc/2251-6093 
856 4 1 |u https://doaj.org/article/de3a056d53dd4eb7b96e87b8b0c975d4  |z Connect to this object online.